Bluotechn
Bluotechn is a biotechnology company based in the United States, specializing in the development of innovative solutions for the treatment of chronic diseases. Founded in 2010, the company focuses on leveraging its expertise in gene therapy and cell-based therapies to address unmet medical needs. Bluotechn's research and development efforts are centered around creating novel therapies that can modulate the immune system, thereby offering potential treatments for conditions such as autoimmune diseases, cancer, and infectious diseases.
The company's approach involves the use of advanced biotechnological techniques, including the engineering of immune cells
Bluotechn's portfolio includes several clinical-stage programs, each aimed at addressing specific medical challenges. The company's commitment